Neuraxis Inc./$NRXS
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Neuraxis Inc.
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).
Ticker
$NRXS
Sector
Primary listing
AMEX
Employees
21
Headquarters
Website
Neuraxis Inc. Metrics
BasicAdvanced
$24M
-
-$1.05
3.11
-
Price and volume
Market cap
$24M
Beta
3.11
52-week high
$6.20
52-week low
$1.33
Average daily volume
50K
Financial strength
Current ratio
2.82
Quick ratio
2.606
Long term debt to equity
5.17
Total debt to equity
9.651
Interest coverage (TTM)
-52.58%
Profitability
EBITDA (TTM)
-6.465
Gross margin (TTM)
84.47%
Net profit margin (TTM)
-222.91%
Operating margin (TTM)
-202.03%
Revenue per employee (TTM)
$150,000
Management effectiveness
Return on assets (TTM)
-83.58%
Return on equity (TTM)
1,427.19%
Valuation
Price to revenue (TTM)
5.626
Price to book
5.66
Price to tangible book (TTM)
5.79
Price to free cash flow (TTM)
-2.896
Free cash flow yield (TTM)
-34.53%
Free cash flow per share (TTM)
-0.843
Growth
Revenue change (TTM)
41.93%
Earnings per share change (TTM)
-59.68%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Neuraxis Inc. stock?
Neuraxis Inc. (NRXS) has a market cap of $24M as of September 11, 2025.
What is the P/E ratio for Neuraxis Inc. stock?
The price to earnings (P/E) ratio for Neuraxis Inc. (NRXS) stock is 0 as of September 11, 2025.
Does Neuraxis Inc. stock pay dividends?
No, Neuraxis Inc. (NRXS) stock does not pay dividends to its shareholders as of September 11, 2025.
When is the next Neuraxis Inc. dividend payment date?
Neuraxis Inc. (NRXS) stock does not pay dividends to its shareholders.
What is the beta indicator for Neuraxis Inc.?
Neuraxis Inc. (NRXS) has a beta rating of 3.11. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.